Search This Blog

Thursday, October 4, 2018

Veeva TAM expanded again but valuation is fair, says JPMorgan


JPMorgan analyst Sterling Auty kept his Neutral rating and $95 price target on Veeva after its Analyst Day presentation. The analyst states that the management has increased its total addressable market estimate to over $9B from $8B indicated in last year’s analyst day while also boosting its operating margin projections and outlining a roadmap for more products. Auty noted however that Veeva’s current multiple presents limited room for upside.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.